MétaCan
Menu
Back to cohort
Record W4319333946 · doi:10.1111/den.14531

Benefits and challenges in implementation of artificial intelligence in colonoscopy: World Endoscopy Organization position statement

2023· review· en· W4319333946 on OpenAlexaff
Yuichi Mori, James E. East, Cesare Hassan, Natalie Halvorsen, Tyler M. Berzin, Michael F. Byrne, Daniel von Renteln, David G. Hewett, Alessandro Repici, Mohan Ramchandani, Maryam Al Khatry, Shin‐ei Kudo, Pu Wang, Honggang Yu, Yutaka Saito, Masashi Misawa, Sravanthi Parasa, Carolina Ogawa Matsubayashi, Haruhiko Ogata, Hisao Tajiri, Nonthalee Pausawasdi, Evelien Dekker, Omer F. Ahmad, Prateek Sharma, Douglas K. Rex

Bibliographic record

VenueDigestive Endoscopy · 2023
Typereview
Languageen
FieldMedicine
TopicColorectal Cancer Screening and Detection
Canadian institutionsUniversité de MontréalCentre Hospitalier de l’Université de MontréalUniversity of British Columbia
FundersOlympusIpsenMitsubishi Tanabe Pharma CorporationNorgineOtsuka PharmaceuticalBraintree LaboratoriesIronwood Pharmaceuticals, IncorporatedPfizerKyorin PharmaceuticalEA Pharma Co., Ltd.Japan Society for the Promotion of ScienceBoston Scientific CorporationEuropean Commission
KeywordsMedicineColonoscopyPosition statementHealth careColorectal cancerMedical physicsFamily medicineCancerInternal medicine

Abstract

fetched live from OpenAlex

The number of artificial intelligence (AI) tools for colonoscopy on the market is increasing with supporting clinical evidence. Nevertheless, their implementation is not going smoothly for a variety of reasons, including lack of data on clinical benefits and cost-effectiveness, lack of trustworthy guidelines, uncertain indications, and cost for implementation. To address this issue and better guide practitioners, the World Endoscopy Organization (WEO) has provided its perspective about the status of AI in colonoscopy as the position statement. WEO Position Statement: Statement 1.1: Computer-aided detection (CADe) for colorectal polyps is likely to improve colonoscopy effectiveness by reducing adenoma miss rates and thus increase adenoma detection; Statement 1.2: In the short term, use of CADe is likely to increase health-care costs by detecting more adenomas; Statement 1.3: In the long term, the increased cost by CADe could be balanced by savings in costs related to cancer treatment (surgery, chemotherapy, palliative care) due to CADe-related cancer prevention; Statement 1.4: Health-care delivery systems and authorities should evaluate the cost-effectiveness of CADe to support its use in clinical practice; Statement 2.1: Computer-aided diagnosis (CADx) for diminutive polyps (≤5 mm), when it has sufficient accuracy, is expected to reduce health-care costs by reducing polypectomies, pathological examinations, or both; Statement 2.2: Health-care delivery systems and authorities should evaluate the cost-effectiveness of CADx to support its use in clinical practice; Statement 3: We recommend that a broad range of high-quality cost-effectiveness research should be undertaken to understand whether AI implementation benefits populations and societies in different health-care systems.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.061
metaresearch head score (Gemma)0.095
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: Not applicable
GenreCandidate signal: Commentary · Consensus signal: Commentary
Teacher disagreement score0.061
Threshold uncertainty score0.325

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0610.095
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0010.002
Bibliometrics0.0020.001
Science and technology studies0.0030.006
Scholarly communication0.0140.009
Open science0.0040.007
Research integrity0.0410.027
Insufficient payload (model declined to judge)0.0040.004

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.129
GPT teacher head0.396
Teacher spread0.267 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreCommentary

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations55
Published2023
Admission routes1
Has abstractyes

Explore more

Same venueDigestive EndoscopySame topicColorectal Cancer Screening and DetectionFrench-language works237,207